Literature DB >> 28827353

Foxp3-independent mechanism by which TGF-β controls peripheral T cell tolerance.

Soyoung A Oh1, Ming Liu1, Briana G Nixon1, Davina Kang1, Ahmed Toure1, Michael Bivona1, Ming O Li2.   

Abstract

Peripheral T cell tolerance is promoted by the regulatory cytokine TGF-β and Foxp3-expressing Treg cells. However, whether TGF-β and Treg cells are part of the same regulatory module, or exist largely as distinct pathways to repress self-reactive T cells remains incompletely understood. Using a transgenic model of autoimmune diabetes, here we show that ablation of TGF-β receptor II (TβRII) in T cells, but not Foxp3 deficiency, resulted in early-onset diabetes with complete penetrance. The rampant autoimmune disease was associated with enhanced T cell priming and elevated T cell expression of the inflammatory cytokine GM-CSF, concomitant with pancreatic infiltration of inflammatory monocytes that triggered immunopathology. Ablation of the GM-CSF receptor alleviated the monocyte response and inhibited disease development. These findings reveal that TGF-β promotes T cell tolerance primarily via Foxp3-independent mechanisms and prevents autoimmunity in this model by repressing the cross talk between adaptive and innate immune systems.

Entities:  

Keywords:  T cell; TGF-β; autoimmunity; tolerance

Mesh:

Substances:

Year:  2017        PMID: 28827353      PMCID: PMC5594672          DOI: 10.1073/pnas.1706356114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  66 in total

1.  Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms.

Authors:  Ming O Li; Shomyseh Sanjabi; Richard A Flavell
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

2.  T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-β1 cytokine.

Authors:  Moses K Donkor; Abira Sarkar; Peter A Savage; Ruth A Franklin; Linda K Johnson; Achim A Jungbluth; James P Allison; Ming O Li
Journal:  Immunity       Date:  2011-07-14       Impact factor: 31.745

Review 3.  TGF-β: guardian of T cell function.

Authors:  Soyoung A Oh; Ming O Li
Journal:  J Immunol       Date:  2013-10-15       Impact factor: 5.422

4.  T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation.

Authors:  Ming O Li; Yisong Y Wan; Richard A Flavell
Journal:  Immunity       Date:  2007-05-03       Impact factor: 31.745

5.  T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function.

Authors:  Jonathan H Esensten; Michael R Lee; Laurie H Glimcher; Jeffrey A Bluestone
Journal:  J Immunol       Date:  2009-06-17       Impact factor: 5.422

6.  FOXP3 induced by CD28/B7 interaction regulates CD25 and anergic phenotype in human CD4+CD25- T lymphocytes.

Authors:  Cristiano Scottà; Marzia Soligo; Cristina Camperio; Enza Piccolella
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

7.  IL-17 and GM-CSF expression are antagonistically regulated by human T helper cells.

Authors:  Rebecca Noster; René Riedel; Mir-Farzin Mashreghi; Helena Radbruch; Lutz Harms; Claudia Haftmann; Hyun-Dong Chang; Andreas Radbruch; Christina E Zielinski
Journal:  Sci Transl Med       Date:  2014-06-18       Impact factor: 17.956

8.  Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus.

Authors:  M G von Herrath; M B Oldstone
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

9.  Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease.

Authors:  A D Cook; E L Braine; I K Campbell; M J Rich; J A Hamilton
Journal:  Arthritis Res       Date:  2001-06-11

10.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  15 in total

Review 1.  Cell-by-cell deciphering of T cells in allergic inflammation.

Authors:  Ting Wen; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2019-11       Impact factor: 10.793

2.  MicroRNA Expression in Clear Cell Renal Cell Carcinoma Cell Lines and Tumor Biopsies: Potential Therapeutic Targets.

Authors:  Samuel Swearson; Aseel O Rataan; Steven Eliason; Brad A Amendt; Yousef Zakharia; Aliasger K Salem; Thai Ho; Youcef M Rustum
Journal:  Int J Mol Sci       Date:  2022-05-17       Impact factor: 6.208

Review 3.  Cancer Stem Cells: The Architects of the Tumor Ecosystem.

Authors:  Briana C Prager; Qi Xie; Shideng Bao; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2019-01-03       Impact factor: 24.633

Review 4.  Mechanisms of Resistance to PD-1 Checkpoint Blockade.

Authors:  Justin C Moser; Siwen Hu-Lieskovan
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

Review 5.  GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches.

Authors:  Frederick M Lang; Kevin M-C Lee; John R Teijaro; Burkhard Becher; John A Hamilton
Journal:  Nat Rev Immunol       Date:  2020-06-23       Impact factor: 53.106

6.  Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition.

Authors:  Lei Gao; Yong Hu; Yahui Tian; Zhenzhen Fan; Kun Wang; Hongdan Li; Qian Zhou; Guandi Zeng; Xin Hu; Lei Yu; Shiyu Zhou; Xinyuan Tong; Hsinyi Huang; Haiquan Chen; Qingsong Liu; Wanting Liu; Gong Zhang; Musheng Zeng; Guangbiao Zhou; Qingyu He; Hongbin Ji; Liang Chen
Journal:  Nat Commun       Date:  2019-04-10       Impact factor: 14.919

7.  Extracellular Vesicles isolated from Mesenchymal Stromal Cells Modulate CD4+ T Lymphocytes Toward a Regulatory Profile.

Authors:  Flavia Franco da Cunha; Vinicius Andrade-Oliveira; Danilo Candido de Almeida; Tamiris Borges da Silva; Cristiane Naffah de Souza Breda; Mario Costa Cruz; Eliana L Faquim-Mauro; Marcos Antonio Cenedeze; Meire Ioshie Hiyane; Alvaro Pacheco-Silva; Regiane Aparecida Cavinato; Ana Claudia Torrecilhas; Niels Olsen Saraiva Câmara
Journal:  Cells       Date:  2020-04-23       Impact factor: 6.600

8.  TGF-β suppresses type 2 immunity to cancer.

Authors:  Ming Liu; Fengshen Kuo; Kristelle J Capistrano; Davina Kang; Briana G Nixon; Wei Shi; Chun Chou; Mytrang H Do; Efstathios G Stamatiades; Shengyu Gao; Shun Li; Yingbei Chen; James J Hsieh; A Ari Hakimi; Ichiro Taniuchi; Timothy A Chan; Ming O Li
Journal:  Nature       Date:  2020-10-21       Impact factor: 69.504

Review 9.  Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus.

Authors:  Takayuki Katsuyama; George C Tsokos; Vaishali R Moulton
Journal:  Front Immunol       Date:  2018-05-17       Impact factor: 7.561

10.  CD226 Attenuates Treg Proliferation via Akt and Erk Signaling in an EAE Model.

Authors:  Ning Wang; Hongyu Yi; Liang Fang; Jingyi Jin; Qianli Ma; Yuting Shen; Juan Li; Shuang Liang; Jie Xiong; Zhuo Li; Hanyu Zeng; Fengliang Jiang; Boquan Jin; Lihua Chen
Journal:  Front Immunol       Date:  2020-08-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.